Skip to main content
. 2018 Jul 26;146(13):1663–1670. doi: 10.1017/S0950268818002005

Table 3.

Prevalence of symptoms in TBE patients (n = 1072) at the moment of discharge from hospital and after 1 month

At the moment of discharge After 1 month
n = 1072 M, n = 668 F, n = 404 P* n M, n = 668 F, n = 404 P* P**
Subjective
Headache 12 (1.1%) 6 (0.9%) 6 (1.5%) 0.38 101 (9.4%) 56 (8.4%) 45 (11.1%) 0.08 <0.05
Vertigo 7 (0.7%) 4 (0.6%) 3 (0.7%) 0.79 29 (2.7%) 22 (3.3%) 7 (1.7%) 0.09 <0.05
Sleep disorders 22 (2.1%) 14 (2.1%) 8 (2%) 0.86 10 (0.9%) 8 (1.2%) 2 (0.5%) 0.23 <0.05
Fatigue 0 (0%) 0 (0%) 0(0%) 47 (4.4%) 34 (5.1%) 13 (3.2%) 0.15 <0.05
n – total 39 (3.6%) 24 (3.6%) 15 (3.7%) 0.99 118 (11%) 70 (10.5%) 48 (11.9%) 0.5 <0.05
Cognitive
Irritability 0 0 0 23 (2.1%) 15 (2.2%) 8 (2%) 0.77 <0.05
Concentration disorders 42 (3.9%) 26 (3.9%) 16 (4%) 1 18 (1.7%) 14 (2.1%) 4 (1%) 0.15 <0.05
Memory impairment 7 (0.7%) 2 (0.3%) 5 (1.2%) 0.07 30 (2.8%) 22 (3.3%) 8 (2%) 0.17 <0.05
 n – total 49 (4.6%) 28 (4.2%) 21(5.2%) 0.48 48(4.5%) 36(5.4%) 12(3%) <0.03 0.91
Psychiatric
Depression 10 (0.9%) 5 (0.7%) 5 (1.2%) 0.43 11 (1%) 6 (0.9%) 5 (1.2%) 0.61 0.82
Anxiety 11 (1%) 5 (0.7%) 6 (1.5%) 0.25 5 (0.5%) 3 (0.4%) 2 (0.5%) 0.93 0.13
Psychotic symptoms 13 (1.2%) 7 (1%) 6 (1.5%) 0.54 1 (0.1%) 0 (0%) 1 (0.2%) <0.05
Psychoorganic symptoms 2 (0.2%) 2 (0.3%) 0 (0%) 2 (0.2%) 2 (0.3%) 0 (0%) 1
n – total 31 (2.9%) 17(2.5%) 14(3.5%) 0.41 16(1.5%) 10(0.9%) 6(1.5%) 0.93 <0.05
Neurological
Upper limbs paresis 34 (3.2%) 21 (3.1%) 13 (3.2%) 0.99 22 (2.1%) 14 (2.1%) 8 (2%) 0.88 0.1
Lower limbs paresis 22 (2.1%) 15 (2.2%) 7 (1.7%) 0.53 10 (0.9%) 6 (0.9%) 4 (1%) 0.9 <0.05
Sensation disorders 14 (1.3%) 7 (1%) 7 (1.7%) 0.34 6 (0.6%) 3 (0.4%) 3 (0.7%) 0.54 0.07
Cranial nerves paresis 23 (2.1%) 11 (1.6%) 12 (3%) 0.14 13 (1.2%) 5 (0.7%) 8 (2%) 0.07 0.1
Cerebellar syndrome 64 (6%) 41 (6.1%) 23 (5.7%) 0.68 13 (1.2%) 9 (1.3%) 4 (1%) 0.58 <0.05
 n – total 101 (9.4%) 60 (9%) 41 (10.1%) 0.57 47 (4.4%) 31 (4.6%) 16 (4%) 0.49 <0.05

*Comparison between males and females.

**Comparison of the overall number of symptoms at the moment of discharge and during the follow-up.